期刊文献+

单纯化疗与放化疗联合治疗在转移性乳腺癌术后患者中应用效果对比 被引量:1

Application effect of simple chemotherapy and combined chemotherapy and radiotherapy in the treatment of patients with metastatic breast cancer after operation
下载PDF
导出
摘要 目的:探讨单纯化疗与放化疗联合治疗在转移性乳腺癌术后患者中的应用效果。方法:收治行转移性乳腺癌手术患者96例,随机分为研究组与对照组。对照组采用单纯化疗,研究组采用放化疗联合治疗,比较两组治疗效果。结果:研究组总有效率和满意率均显著高于对照组(P<0.05)。两组不良反应差异无统计学意义(P>0.05)。结论:放化疗联合治疗在转移性乳腺癌术后患者中的应用效果更优。 Objective:To explore the application effect of simple chemotherapy and combined chemotherapy and radiotherapy in the treatment of patients with metastatic breast cancer after operation.Methods:96 patients with metastatic breast cancer after operation were selected.They were randomly divided into the study group and the control group.The control group was treated with chemotherapy alone.The study group was treated with combined chemotherapy and radiotherapy.We compared the treatment effect of two groups.Results:In the study group,the total effective rate and satisfaction rate were significantly higher than those in the control group(P〈0.05).There was no significant difference in adverse reactions between groups(P〈0.05).Conclusion:The application effect of combined chemotherapy and radiotherapy in the treatment of patients with metastatic breast cancer after operation was better.
作者 南征
出处 《中国社区医师》 2017年第35期39-40,共2页 Chinese Community Doctors
关键词 转移性乳腺癌 单纯化疗 放化疗 Metastatic breast cancer Simple chemotherapy Combined chemotherapy and radiotherapy
  • 相关文献

参考文献7

二级参考文献113

  • 1Davies C,Godwin J,Gray R,et al.Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen:patient-level meta-analysis of randomised trials[J].Lancet,2011,378(9793):771-784.
  • 2Hortobagyi GN.Treatment of breast cancer[J].N Engl J Med,1998,339(14):974-984.
  • 3Cardoso F,Costa A,Norton L,et al.ESO-ESMO 2nd international consensus guidelines for advanced breast cancer(ABC2)dagger[J].Ann Oncol,2014,25(10):1871-1888.
  • 4Wilcken N,Hornbuckle J,Ghersi D.Chemotherapy alone versus endocrine therapy alone for metastatic breast cancer[J].Cochrane Database Syst Rev,2003(2):CD002747.
  • 5Sledge GW,Neuberg D,Bernardo P,et al.Phase III trial of doxorubicin,paclitaxel,and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer:an intergroup trial(E1193)[J].J Clin Oncol,2003,21(4):588-592.
  • 6Fossati R,Confalonieri C,Torri V,et al.Cytotoxic and hormonal treatment for metastatic breast cancer:a systematic review of published randomized trials involving 31,510 women[J].J Clin Oncol,1998,16(10):3439-3460.
  • 7Carrick S,Parker S,Thornton CE,et al.Single agent versus combination chemotherapy for metastatic breast cancer[J].Cochrane Database Syst Rev,2009(2):CD003372.
  • 8Cardoso F,Bedard PL,Winer EP,et al.International guidelines for management of metastatic breast cancer:combination vs sequential single-agent chemotherapy[J].J Natl Cancer Inst,2009,101(17):1174-1181.
  • 9Dear RF,Mc Geechan K,Jenkins MC,et al.Combination versus sequential single agent chemotherapy for metastatic breast cancer[J].Cochrane Database Syst Rev,2013,12:CD008792.
  • 10A'Hern RP,Smith IE,Ebbs SR.Chemotherapy and survival in advanced breast cancer:the inclusion of doxorubicin in Cooper type regimens[J].Br J Cancer,1993,67(4):801-805.

共引文献78

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部